Home › Funds › BlackRock Inc › PHVS
BlackRock Inc position in PHVS
PHARVARIS N V · Health Care
Latest position (Q2 2026)771.45K sh
Reported value held$26.68M
Portfolio Weight0.00%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 195.35K | $3.62M | New |
| Q4 2024 | 194.19K | $3.72M | Reduce |
| Q1 2025 | 192.87K | $3.03M | Reduce |
| Q2 2025 | 201.09K | $3.54M | Add |
| Q3 2025 | 414.42K | $10.34M | Add |
| Q4 2025 | 708.56K | $19.66M | Add |
| Q1 2026 | 757.21K | $21.39M | Add |
| Q2 2026 | 771.45K | $26.68M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PHVS
- Fidelity Management & Research (FMR) 6.57M sh · $227.03M · Q2 2026
- Viking Global Investors 3.65M sh · $126.33M · Q2 2026
- Wellington Management Group 2.39M sh · $82.75M · Q2 2026
- Point72 Asset Management 1.64M sh · $56.75M · Q2 2026
- Balyasny Asset Management 524.30K sh · $18.13M · Q2 2026
- D. E. Shaw & Co 471.40K sh · $16.30M · Q2 2026
- Millennium Management 427.40K sh · $14.78M · Q2 2026
- UBS Group AG 254.79K sh · $8.81M · Q2 2026
- Citadel Advisors 250.38K sh · $8.66M · Q2 2026
- Two Sigma Investments 216.64K sh · $7.49M · Q2 2026
- Goldman Sachs Group 149.98K sh · $5.19M · Q2 2026